" class="no-js "lang="en-US"> Brian Vandahl - Medtech Alert
Sunday, November 10, 2024
Brian Vandahl

Brian Vandahl

About Brian Vandahl

Brian holds an MSc in Molecular Biology and has a PhD from Health, AU.

Brian has previously worked as a research scientist at Statens Serum Institut and Novo Nordisk A/S.

Brian has a great deal of experience in the field of biotechnological research with a focus on development of protein-based pharmaceuticals.

He currently works as Corporate Vice President at Novo Nordisk A/S, where he is heading an organisation of approximately 120 people responsible for various aspects of recombinant technologies in research projects. The organisation is part of the Global Research Technologies area, which is responsible for the molecules investigated in Research at Novo Nordisk across all therapy areas.

Related Story

Ginkgo Bioworks and Novo Nordisk to Collaborate on Expression Systems for Pharmaceutical Products

June 8 2022

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a collaboration with Novo […]